Press Releases

ROCHESTER, Minn., Sept. 19, 2019 /PRNewswire/ -- WuXi Diagnostics announced today the plan to open its first U.S.-based research and diagnostic testing development facility in Rochester, Minnesota to accelerate esoteric diagnostic product development, and bring more personalized and accurate clinical diagnosis services for global patient

ATLANTA and MIAMI, Sept. 19, 2019 /PRNewswire/ -- Vivex Biologics, Inc., a leading Regenerative Medicine company, announced today that Peter Wehrly has been appointed the new CEO. Mr. Wehrly is a seasoned leader in the medical device and biotech industries that consistently delivers top-line growth and operational efficiencies.

NASHVILLE, Tenn., Sept. 19, 2019 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ: TVTY) will present at the 2019 Cantor Global Healthcare Conference to be held October 2-4, 2019 in New York, NY. Donato Tramuto, Tivity Health's chief executive officer, will participate in a fir

LEXINGTON, Mass., Sept. 19, 2019 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF), for the potent

HOUSTON and VANCOUVER, Sept. 19, 2019 /PRNewswire/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be presenting at the Ladenburg Thalmann Helathcare Conference on

TSX:IN OTCQX:IMLFF VANCOUVER, Sept. 19, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline of medications targeting diseases w

SUNNYVALE, Calif., Sept. 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today published an informational guide designed to help radiation oncology practices understand the complexities of the much-anticipated proposed Medicare & Medicaid reimbursement changes. The new guide — available at

VAUGHAN, Ontario, Sept. 19, 2019 /PRNewswire/ --

VAUGHAN, ON, Sept. 19, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) has received notice from the Alberta Gaming, Liquor and Cannabis Commission (the "AGLC"), the Crown corporation in charge of wholesale distribution of cannabis products to licensed cannabis retailers in Alberta, advisi

GARDENA, Calif., Sept. 19, 2019 /PRNewswire/ -- Innovet Pet announced today that they have acquired Tindog.co — a popular app known for helping dog owners expand their social circl